DNA damage repair and response are critical in CML cells, and error-prone DNA repair is among the likely causes of the bcr-abl fusion gene alterations because of its relatively faithless ligation, that also may further results in resistance to BCR-ABL tyrosine kinase inhibitors [32]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.